Expanded clinical trial for blood cancer patients in Auckland and Christchurch
The Malaghan Institute is extending its phase 2 clinical trial for CAR T-cell therapy to Auckland and Christchurch. This treatment involves modifying a patient's own immune cells in a laboratory to target and destroy cancer cells.

